Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Alaska Doctors Could Be Disciplined for Providing Transgender Care for Minors

Alaska medical professionals who provide gender-affirming care for children could risk disciplinary action under proposed changes to state regulations approved by the state medical board on Friday. The board unanimously approved draft language that would add those providing medical or surgical intervention to “treat gender dysphoria or facilitate gender transition” to a state regulation outlining […]

Consider Psychologic Evaluation for Children With Urinary Incontinence

Urinary incontinence (UI) minimally affected academic performance except in children with psychiatric disorders. Children with UI and attention deficit-hyperactivity disorder had the worst academic outcomes versus reference groups. The authors recommended a psychiatric evaluation for children with UI before starting treatment. Pediatric urinary incontinence (UI) did not appear to substantially affect academic performance but the […]

FDA Approves Nipocalimab for Adult and Pediatric Myasthenia Gravis

The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) or anti-muscle-specific kinase (MuSK) antibody positive, Johnson & Johnson announced Wednesday. Nipocalimab is designed to block the immunoglobulin G (IgG) binding site on the neonatal Fc receptor (FcRn) to reduce […]

Oral Corticosteroids Ease Preschoolers’ Acute Wheeze

Oral corticosteroids helped reduce wheeze severity and length of hospital stay in children experiencing acute preschool wheeze, a pooled analysis of patient-level randomized trial data showed. The medication reduced wheezing severity score (WSS) after 4 hours to a greater degree than did placebo (mean difference -0.31 on a 12-point scale, P=0.011). This, however, was not […]

Pediatric Neuron Disease Gets Its First Gene Therapy

The FDA approved atidarsagene autotemcel (arsa-cel; Lenmeldy), the first gene therapy to treat children with pre-symptomatic late infantile, pre-symptomatic early juvenile, or early symptomatic early juvenile metachromatic leukodystrophy (MLD), the agency announced on Monday. “This is the first FDA-approved treatment option for children who have this rare genetic disease,” Peter Marks, MD, PhD, director of […]

DBN Health News